Identification of an immunological prognostic factor for metastatic colorectal cancer patients treated with first-line oxaliplatin-based chemotherapy

被引：0
|
作者：
Tada, K. [1 ,2 ]
Shoji, H. [3 ]
Kitano, S. [4 ]
Nishimura, T. [5 ]
Shimada, Y. [3 ]
Nagashima, K. [6 ]
Ito, A. [7 ]
Honma, Y. [3 ]
Iwasa, S. [3 ]
Okita, N. [3 ]
Takashima, A. [3 ]
Kato, K. [3 ]
Yamada, Y. [3 ]
Katayama, N. [8 ]
Boku, N. [3 ]
Heike, Y. [1 ]
Hamaguchi, T. [3 ]
机构：
[1] St Lukes Int Hosp, Immunotherapy & Cell Therapy Serv, Tokyo, Japan
[2] Natl Canc Ctr, Div Canc Immunotherapy, Tokyo, Japan
[3] Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan
[4] Natl Canc Ctr, Dept Expt Therapeut, Tokyo, Japan
[5] Tokyo Jikei Med Univ, Gastrointestinal Med Div, Tokyo, Japan
[6] Chiba Univ, Dept Global Clin Res, Chiba, Japan
[7] Natl Canc Ctr, Hematopoietci Stem Cell Transplant Div, Tokyo, Japan
[8] Mie Univ, Dept Hematol & Oncol, Tsu, Mie 514, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)30240-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
406
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [31] Changes in Immunological Status in Patients With Metastatic Colorectal Cancer Treated With First-line Chemoimmunotherapy
    Yamada, Teppei
    Yoshida, Yoichiro
    Maeda, Toshiki
    Yoshimatsu, Gumpei
    Aisu, Naoya
    Yamashita, Kanefumi
    Komono, Akira
    Kajitani, Ryuji
    Matsumoto, Yoshiko
    Nagano, Hideki
    Naito, Keiko
    Yasumoto, Kosei
    Takimoto, Rishu
    Kamigaki, Takashi
    Goto, Shigenori
    Yoshimura, Fumihiro
    Sakata, Naoaki
    Kodama, Shohta
    Hasegawa, Suguru
    ANTICANCER RESEARCH, 2020, 40 (08) : 4763 - 4771
  • [32] Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC)
    Berretta, Massimiliano
    Zanet, Ernesto
    Nasti, Guglielmo
    Lleshi, Arben
    Frustaci, Sergio
    Fiorica, Francesco
    Bearz, Alessandra
    Talamini, Renato
    Lestuzzi, Chiara
    Lazzarini, Renzo
    Fisichella, Rossella
    Cannizzaro, Renato
    Iaffaioli, Rosario Vincenzo
    Berretta, Salvatore
    Tirelli, Umberto
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2012, 55 (02) : 271 - 275
  • [33] Organic cation transporter 2 and tumor budding as independent prognostic factors in metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy
    Tatsumi, Shigenobu
    Matsuoka, Hiroshi
    Hashimoto, Yumi
    Hatta, Kohei
    Maeda, Kotaro
    Kamoshida, Shingo
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (01): : 204 - 212
  • [34] Second-line bevacizumab plus FOLFOX in patients with metastatic colorectal cancer previously treated with adjuvant oxaliplatin-based chemotherapy.
    Chun, Sang Hoon
    Kim, Jung Hoon
    Kwag, Seung-Jin
    Kang, Myoung Hee
    Park, Ji-Ho
    Lee, Gyeong-Won
    Kang, Jung Hun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 157 - 157
  • [35] Making sense of anti-EGFR plus oxaliplatin-based therapy in the first-line treatment of metastatic colorectal cancer
    Fakih, Marwan G.
    FUTURE ONCOLOGY, 2011, 7 (02) : 223 - 226
  • [36] The effect of DNA mismatch repair (MMR) status on oxaliplatin-based first-line chemotherapy as in recurrent or metastatic colon cancer
    Kim, Seung Tae
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Lim, Ho Yeong
    Kang, Won Ki
    Kim, Jin Yong
    Kim, Young Ho
    Chang, Dong Kyung
    Rhee, Poong-Lyul
    Kim, Dae Shick
    Yun, Haeran
    Cho, Yong Beom
    Kim, Hee Cheol
    Yun, Seong Hyeon
    Chun, Ho-Kyung
    Lee, Woo Yong
    Park, Young Suk
    MEDICAL ONCOLOGY, 2010, 27 (04) : 1277 - 1285
  • [37] Prognostic factors and applicability of Kohne's prognostic groups in stage IV colorectal cancer patients treated with first-line oxaliplatin and/or irinotecan-based chemotherapy
    Diaz, Roberto
    Aparicio, Jorge
    Segura, Angel
    Pellin, Lorena
    Guerrero, Angel
    Palomar, Laura
    Molina, Jorge
    Gimenez, Sandra
    Ponce, Jose
    Montalar, Joaquin
    ANNALS OF ONCOLOGY, 2004, 15 : 87 - 87
  • [38] Oxaliplatin-based Chemotherapy in Patients Aged 75 Years or Older with Metastatic Colorectal Cancer
    Fukuchi, Minoru
    Ishibashi, Keiichiro
    Tajima, Yusuke
    Okada, Norimichi
    Yokoyama, Masaru
    Chika, Noriyasu
    Hatano, Satoshi
    Matsuzawa, Takeaki
    Kumamoto, Kensuke
    Kumagai, Youichi
    Baba, Hiroyuki
    Mochiki, Erito
    Ishida, Hideyuki
    ANTICANCER RESEARCH, 2013, 33 (10) : 4627 - 4630
  • [39] Genome-wide study of genetic polymorphisms predictive for outcome from first-line oxaliplatin-based chemotherapy in colorectal cancer patients
    Park, Hanla A.
    Edelmann, Dominic
    Canzian, Federico
    Seibold, Petra
    Harrison, Tabitha A.
    Hua, Xinwei
    Shi, Qian
    Silverman, Allison
    Benner, Axel
    Macauda, Angelica
    Schneider, Martin
    Goldberg, Richard M.
    Alberts, Steven R.
    Hoffmeister, Michael
    Brenner, Hermann
    Chan, Andrew T.
    Peters, Ulrike
    Newcomb, Polly A.
    Chang-Claude, Jenny
    INTERNATIONAL JOURNAL OF CANCER, 2023, 153 (09) : 1623 - 1634
  • [40] The effect of DNA mismatch repair (MMR) status on oxaliplatin-based first-line chemotherapy as in recurrent or metastatic colon cancer
    Seung Tae Kim
    Jeeyun Lee
    Se Hoon Park
    Joon Oh Park
    Ho Yeong Lim
    Won Ki Kang
    Jin Yong Kim
    Young Ho Kim
    Dong Kyung Chang
    Poong-Lyul Rhee
    Dae Shick Kim
    Haeran Yun
    Yong Beom Cho
    Hee Cheol Kim
    Seong Hyeon Yun
    Ho-Kyung Chun
    Woo Yong Lee
    Young Suk Park
    Medical Oncology, 2010, 27 : 1277 - 1285
12345